EHRA Premium Access

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - CON

Congress Presentation

About the speaker

Associate Professor Tatjana Potpara

School of Medicine, Belgrade University, Belgrade (Serbia)
43 presentations
3 followers

11 more presentations in this session

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism- PRO

Speaker: Doctor S. Themistoclakis (Venice, IT)

Thumbnail

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal PRO

Thumbnail

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal CON

Thumbnail

Chairperson conclusion & Closing question

Thumbnail

Access the full session

Tough decisions in anticoagulation in atrial fibrillation

Speakers: Associate Professor T. Potpara, Doctor S. Themistoclakis
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb